The Lawyer’s newest product is the most comprehensive overview of the Asia-Pacific legal market yet produced. With rankings of the top 100 local law firms by lawyer headcount as well as analysis of the leading 50 international players in the region, it is essential reading for anyone interested in the strategic future of the world’s fastest growing legal market
Jonathan Lamb, ex-legal adviser at Shire Pharma-ceuticals Group, has left the company to join specialist pharmaceutical company Amarin Corporation as its first general counsel and company secretary
Lamb joined the corporation after two years of service at Shire, where he played an active role in the company's merger with Canadian company BioChem Pharma in 2001. "It's a very good opportunity for me at this time," said Lamb. "Shire is getting larger and becoming more process-bound, and I'm more suited to a smaller environment." Tatiana May - who joined Shire a year ago from AstraZeneca - remains as the company's general counsel and company secretary. Shire's legal team in the UK is currently expanding, with two new in-house lawyers joining the company in May. Although Shire does have an international presence, the majority of Shire's operations which are Nasdaq-listed are based in the US, where New York law firm Cahill Gordon & Reindel are its preferred advisers. Amarin is also listed on Nasdaq and all of its sales and business development teams are based in the US. Historically, in the UK Amarin uses Owen Waft, a partner in the healthcare and pharmaceuticals department at Nicholson Graham & Jones. In the US the company turns to Scott Ziegler, name partner at New York firm Ziegler Ziegler & Altman. Lamb said he is very open-minded concerning the choice of legal advisers, but has formed a favourable impression of Nicholsons during the short time he has so far spent at Amarin.